Disc Medicine Income Statement (2020-2026) | IRON

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
4.31M4.32M4.32M4.32M4.33M1.04M19.58M22.85M24.14M24.36M24.70M29.71M29.75M29.87M34.58M34.69M35.01M37.89M38.19M38.39M
Operating items
Research & Development (Quarter)
13.46M-10.91M7.82M7.71M7.89M10.02M20.18M12.10M14.42M22.57M23.70M23.48M24.68M24.80M27.76M46.32M50.33M46.22M45.90M46.93M
Selling, General & Administrative (Quarter)
5.00M-9.41M2.14M4.30M2.59M5.00M4.95M5.23M4.54M7.15M7.76M7.37M8.17M9.75M12.18M15.09M17.36M20.75M23.62M18.14M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
18.45M-20.33M9.96M12.02M10.48M15.02M25.12M17.33M18.96M29.71M31.46M30.85M32.86M34.55M39.95M61.41M67.70M66.97M69.52M65.08M
Operating Income (Quarter)
-18.45M20.33M-9.96M-12.02M-10.48M-15.02M-25.12M-17.33M-18.96M-29.71M-31.46M-30.85M-32.86M-34.55M-39.95M-61.41M-67.70M-66.97M-69.52M-65.08M
EBIT (Quarter)
-18.45M20.33M-9.96M-12.02M-10.48M-15.02M-25.12M-17.33M-18.96M-29.71M-31.46M-30.85M-32.86M-34.55M-39.95M-61.41M-67.70M-66.97M-69.52M-65.08M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.00M0.01M0.04M0.27M0.39M2.37M2.91M4.84M4.68M4.52M4.57M6.36M5.84M6.88M7.06M6.41M7.41M6.89M6.53M
Other Non Operating Income (Quarter)
-5.05M0.10M-5.94M-0.01M0.01M-0.01M-0.00M-0.01M0.01M0.00M-0.00M0.07M-0.02M-0.00M0.02M-0.01M
Non Operating Income (Quarter)
0.11M2.44M-5.67M3.78M2.37M1.41M4.86M6.17M4.52M4.56M6.37M5.27M5.98M6.21M5.48M6.53M6.07M5.61M
Net income details
EBT (Quarter)
-18.55M20.34M-9.85M-9.58M-16.15M-11.24M-22.76M-15.92M-14.10M-23.55M-26.94M-26.29M-26.48M-29.28M-33.97M-55.20M-62.22M-60.44M-63.45M-59.46M
Tax Provisions (Quarter)
0.02M0.08M0.02M-0.00M0.06M0.11M0.35M0.10M-44.76M0.10M0.07M
Profit After Tax (Quarter)
-18.55M18.08M-9.85M-9.58M-16.15M-11.24M-22.78M-15.95M-14.12M-23.58M-26.95M-26.35M-26.60M-29.46M-34.09M-55.25M-62.32M-60.53M-63.50M-59.53M
Income from Continuing Operations (Quarter)
-18.55M20.34M-9.85M-9.58M-16.15M-11.24M-22.78M-16.00M-14.12M-23.55M-26.94M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M-59.53M
Consolidated Net Income (Quarter)
-18.55M20.34M-9.85M-9.58M-16.15M-11.24M-22.78M-16.00M-14.12M-23.55M-26.94M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M-59.53M
Income towards Parent Company (Quarter)
-18.55M20.34M-9.85M-9.58M-16.15M-11.24M-22.78M-16.00M-14.12M-23.55M-26.94M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M-59.53M
Net Income towards Common Stockholders (Quarter)
-18.55M20.34M-9.85M-9.58M-16.15M-11.24M-22.78M-15.95M-14.12M-23.58M-26.95M-26.35M-26.60M-29.64M-33.97M-55.20M-62.32M-15.69M-63.55M-59.53M
Additional items
EPS (Basic) (Quarter)
-4.305.04-2.28-2.22-3.73-10.82-1.20-0.74-0.58-1.06-1.09-1.03-0.89-1.07-1.02-1.58-1.77-0.44-1.65-1.54
EPS (Diluted) (Quarter)
-4.3023.15-10.67-2.22-3.73-10.82-1.20-0.74-0.58-1.06-1.09-1.03-0.89-1.07-1.02-1.58-1.77-0.44-1.65-1.54
Shares Outstanding (Quarter)
4.31M4.04M4.32M4.32M4.33M1.04M18.95M21.48M24.32M22.32M24.81M25.65M29.94M27.61M33.32M35.02M35.18M35.30M38.49M38.69M
Shares Outstanding (Diluted) (Quarter)
4.31M0.88M0.92M4.32M4.33M1.04M18.95M21.48M24.32M22.32M24.81M25.65M29.94M27.61M33.32M35.02M35.18M35.30M38.49M38.69M
EBITDA (Quarter)
-18.45M20.33M-9.96M-12.02M-10.48M-15.02M-25.12M-17.33M-18.96M-29.71M-31.46M-30.85M-32.86M-34.55M-39.95M-61.41M-67.70M-66.97M-69.52M-65.08M
Interest Expenses (Quarter)
0.10M-0.01M0.10M0.10M0.04M0.09M28.07M82.59M86.19M-0.19M114.37M0.20M1.65M1.55M1.45M1.48M1.25M2.10M
Tax Rate (Quarter)
-0.10-0.48-0.140.00-0.23-0.43-1.21-0.1674.05-0.16-0.12